Comparative cost-effectiveness of a fluticasone-propionate/salmeterol combination versus anticholinergics as initial maintenance therapy for chronic obstructive pulmonary disease

PURPOSE: Relative costs and utilization-related outcomes of a fluticasone propionate 250 μg + salmeterol 50 μg combination (FSC), tiotropium bromide, and ipratropium as initial maintenance therapy in COPD have not been compared in a commercially-insured population. METHODS: This retrospective, obser...

Descripción completa

Detalles Bibliográficos
Autores principales: Dalal, Anand A, Roberts, Melissa H, Petersen, Hans V, Blanchette, Christopher M, Mapel, Douglas W
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034283/
https://www.ncbi.nlm.nih.gov/pubmed/21311689
http://dx.doi.org/10.2147/COPD.S15455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034283/
https://www.ncbi.nlm.nih.gov/pubmed/21311689
http://dx.doi.org/10.2147/COPD.S15455

Ejemplares similares